Friulia sostiene il consolidamento finanziario di Friulchem, azienda specializzata nella trasformazione di principi attivi per la produzione di farmaci e medicinali generici in ambito …

A new look for Evultis In the next forthcoming CPhI China, you will be able to discover more on Evultis products and …

CPhI China 2018 Visit CPhI China Friulchem is glad to meet you at Kerry Hotel – Club Lounge meeting room 2 for …

Visit CPhI Japan 2018 CPhI Japan is the opportunity to meet the country’s industry leaders.This event has been the central platform for …

Chinese New Year 2018 – Year of the Dog Chinese New Year, also known as the Spring Festival in modern China, often …

CPhI Japan 2018 Friulchem will attend to CPhI Japan 2018. CPhI Japan is Japan’s most comprehensive pharma event, which brings together more …

A new collaboration in China The group Evultis SA – Friulchem S.p.A. started a new collaboration in China that allows it to …

Friulchem Reports on Patent Ruling for Rifaximin DCAT Value Chain Insights published a new article on Patent Ruling for Rifaximin. Mexican Institute …

Friulchem S.p.A. filed patents for FC-Cubes for pets & horses Friulchem S.p.A. has filed FC-Cubes patents in EU, US, BRASIL, AUSTRALIA, and …